Name of bioresource/bank

CBC Biotec Biobank

Name of Principal Investigator
Title Doctor
First name ZABOT
Last name Marie-Therese
Address of institution where award is held
Institution Hospices Civils de Lyon
Street Address BP 2251 – 3 quai des Celestins
City LYON Cedex 02
Postcode 69229
Country
  • France
  • Website

    http://www.chu-lyon.fr

    Contact email (e.g. manager or coordinator)

    marie-therese.zabot@chu-lyon.fr

    Funding source
    Q1 What conditions does your resource cover?
  • Motor neurone diseases
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA)
  • Neurodegenerative disease in general
  • Q2a What DNA collection does your resources hold?
  • 101-1000 donors
  • Q2b What cell lines does your resource hold?
  • Above 1000 distinct cell lines
  • Q2c What tissue (including post-mortem tissue) does your resource hold?
  • 1-100 donors
  • Q3 Are human tissues/samples/DNA from
  • Living donors: blood derivatives
  • Living donors: DNA
  • Living donors: skeletal muscle biopsy
  • Living donors: other, please specify below
  • Post-mortem donors: other (specify)
  • Q4 Are tissues/samples/DNA from
  • Healthy individuals/control donors
  • Patients
  • Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
  • Routinely collected as medical records
  • In a specific study-associated dataset
  • Collected as part of a specific clinical trial(s)
  • Q6 In what form are samples supplied?
  • Secondary samples:(derivatives of primary samples)
  • Secondary samples: DNA
  • Secondary samples: cell lines derived from primary samples
  • Secondary samples: other types of cell lines
  • Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
  • In most samples
  • Q8 What is the status of your tissue/sample/DNA collection?
    Q9 What are the rules and procedures for access?
  • Apply to PI or co-ordinator at resource
  • Access Committee mechanism
  • International access
  • Access to industry
  • Access for pilot studies permitted
  • Access restricted to peer-reviewed work
  • Applicant needs to provide separate external ethics approval
  • Resource has own ethics approval so usually no need for separate external ethics approval
    Types: Biobanks
    Member States: N/A
    Diseases: N/A
    Years: 2011
    Database Categories: N/A
    Database Tags: N/A

    Export as PDF